Molecular characterization of prostate hyperplasia in prolactin Transgenic mice by using cDNA representational difference analysis

被引:11
作者
Dillner, K
Kindblom, J
Flores-Morales, A
Pang, ST
Törnell, J
Wennbo, H
Norstedt, G
机构
[1] Univ Gothenburg, Dept Physiol & Pharmacol, Gothenburg, Sweden
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Chang Gung Mem Hosp, Dept Surg, Div Urol, Tao Yuan, Taiwan
[4] AstraZeneca R&D, Astra Transgen Ctr, Molndal, Sweden
[5] AstraZeneca R&D, Integrat Pharmacol, Molndal, Sweden
关键词
prostatic hyperplasia; gene expression analysis; prolactin-transgenic; mouse; prolactin;
D O I
10.1002/pros.10102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Transgenic mice overexpressing the rat prolactin (PRL) gene develop a dramatic enlargement of the prostate gland. The objective of this study was to characterize the molecular mechanisms in the prostate of importance for the prostate hyperplasia seen in these transgenic mice. METHODS. cDNA representational difference analysis (cDNA RDA) was used to isolate differentially expressed transcripts in the prostate hyperplasia of the transgenic mice compared with wildtype littermates. Furthermore, cDNA microarray analysis was used to verify the RDA output. RESULTS. Here we report 10 transcripts, some of them described to be involved in proliferation and apoptosis, which are differentially expressed in the enlarged transgenic prostates compared with controls. CONCLUSION. The identified differentially expressed transcripts presented herein supports molecular similarities between the prostate hyperplasia of PRL-transgenic mice and human BPH that may contribute to explain the molecular basis of prostate hyperplasia.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 64 条
[1]   CYTOKERATIN POLYPEPTIDE PATTERNS OF DIFFERENT EPITHELIA OF THE HUMAN MALE UROGENITAL TRACT - IMMUNOFLUORESCENCE AND GEL-ELECTROPHORETIC STUDIES [J].
ACHTSTATTER, T ;
MOLL, R ;
MOORE, B ;
FRANKE, WW .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1985, 33 (05) :415-426
[2]   Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture [J].
Ahonen, TJ ;
Härkönen, PL ;
Laine, J ;
Rui, H ;
Martikainen, PM ;
Nevalainen, MT .
ENDOCRINOLOGY, 1999, 140 (11) :5412-5421
[3]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[4]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[5]   ACTION OF PROLACTIN IN REGRESSING PROSTATE - INDEPENDENT OF ACTION MEDIATED BY ANDROGEN RECEPTORS [J].
ASSIMOS, D ;
SMITH, C ;
LEE, C ;
GRAYHACK, JT .
PROSTATE, 1984, 5 (06) :589-595
[6]  
Bierhoff E, 1997, PROSTATE, V31, P234, DOI 10.1002/(SICI)1097-0045(19970601)31:4<234::AID-PROS4>3.0.CO
[7]  
2-K
[8]  
BOSCH RJLH, 1991, EUR UROL, V20, P27
[9]  
Carulli JP, 1998, J CELL BIOCHEM, P286
[10]   Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate - An immunocytochemical study with monoclonal antibodies [J].
Castellucci, E ;
PrayerGaletti, T ;
Roelofs, M ;
Pampinella, F ;
Faggian, L ;
Gardiman, M ;
Pagano, F ;
Sartore, S .
BASIS FOR CANCER MANAGEMENT, 1996, 784 :496-508